EUVIMEDEUVIMED entdecken
Crossref

Current and future burden of female breast cancer in the Middle East and North Africa region using estimates from GLOBOCAN 2022

Mariam Zahwe iD, Karima Bendahhou, Sultan Eser, Deborah Mukherji, Heba Fouad, Ibtihal Fadhil, Isabelle Soerjomataram iD, Ariana Znaor iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Mariam Zahwe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most diagnosed female cancer and the most common cause of cancer death in women in the Middle East and North Africa (MENA) region. In this study, we aimed to describe the current patterns of breast cancer among women in the MENA region and estimate the burden for the year 2050. We used the estimates of the breast cancer incidence and mortality from the GLOBOCAN 2022 database and predicted the burden of breast cancer in 2050 according to different scenarios. With 118,200 new breast cancer cases and 41,000 deaths, breast cancer contributed to 25% of cancer incidence and almost 20% of cancer mortality among women in MENA. The highest incidence rates were in Algeria and Iraq (≥60/100,000) and the lowest rates in Saudi Arabia and Yemen (20/100,000), and the lowest in Saudi Arabia (7.6/100,000). While the incidence rates were low compared to other world regions, the mortality rates (16.9/100,000) were higher than in any other world region except Sub‐Saharan Africa. The incidence rates for women

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleAfrica, NorthernMiddle EastIncidenceMiddle AgedAdultAgedCost of IllnessYoung Adult

Stichwörter der Autor:innen

Middle East and North Africabreast cancerburdenincidencemortality

Autor:innen und Institutionen

  • Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
  • Casablanca Cancer Registry, Ibn Rochd Hospital, Casablanca, Morocco.
  • Faculty of Medicine, Balikesir University, Balikesir, Türkiye.
  • Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
  • Clemenceau Medical Center Dubai, Dubai, United Arab Emirates.
  • Noncommunicable Diseases Surveillance, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.

ORCID-Profile: Mariam Zahwe, Isabelle Soerjomataram, Ariana Znaor

Förderung

  • World Health Organization

Zitieren

APA

Zahwe, M., Bendahhou, K., Eser, S., Mukherji, D., Fouad, H., Fadhil, I., Soerjomataram, I., & Znaor, A. (2025). Current and future burden of female breast cancer in the Middle East and North Africa region using estimates from GLOBOCAN 2022. International Journal of Cancer. https://doi.org/10.1002/ijc.35325

Vancouver

Zahwe M, Bendahhou K, Eser S, Mukherji D, Fouad H, Fadhil I, et al. Current and future burden of female breast cancer in the Middle East and North Africa region using estimates from GLOBOCAN 2022. International Journal of Cancer. 2025. doi:10.1002/ijc.35325

BibTeX
@article{Zahwe2025,
  author = {Zahwe, Mariam and Bendahhou, Karima and Eser, Sultan and Mukherji, Deborah and Fouad, Heba and Fadhil, Ibtihal and Soerjomataram, Isabelle and Znaor, Ariana},
  title = {Current and future burden of female breast cancer in the Middle East and North Africa region using estimates from GLOBOCAN 2022},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35325}
}
Kostenlos starten →